LSCNX
Price
$26.19
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VSCIX
Price
$120.70
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

LSCNX vs VSCIX

Header iconLSCNX vs VSCIX Comparison
Open Charts LSCNX vs VSCIXBanner chart's image
Loomis Sayles Small Cap Value N
Price$26.19
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index I
Price$120.70
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
LSCNX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LSCNX vs. VSCIX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSCNX is a Buy and VSCIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 151B vs. LSCNX (416M). VSCIX pays higher dividends than LSCNX: VSCIX (1.43) vs LSCNX (0.23). LSCNX was incepted earlier than VSCIX: LSCNX (12 years) vs VSCIX (27 years). LSCNX is a more actively managed with annual turnover of: 26.00 vs. VSCIX (12.00). LSCNX has a lower initial minimum investment than VSCIX: LSCNX (1000000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 32.13 vs. LSCNX (6.98). VSCIX return over 5 years is better than : 59.15 vs. LSCNX (-9.92).
LSCNXVSCIXLSCNX / VSCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years27 years-
Gain YTD17.49718.40495%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets416M151B0%
Annual Yield % from dividends0.231.4316%
Returns for 1 year6.9832.1322%
Returns for 3 years-24.837.14-348%
Returns for 5 years-9.9259.15-17%
Returns for 10 years-31.50128.63-24%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHVS20.150.31
+1.56%
Pharvaris NV
BOX34.670.43
+1.26%
BOX
TSCO278.75-0.44
-0.16%
Tractor Supply Company
XGN2.75-0.04
-1.43%
Exagen
AMTX4.11-0.51
-11.04%
Aemetis